Theratechnologies RSI
¿Qué es el RSI de Theratechnologies?
El RSI de Theratechnologies, Inc. es 36.47
¿Cuál es la definición de RSI?
El índice de fortaleza relativa (RSI 14) es un indicador de impulso que compara la magnitud de las ganancias y pérdidas durante un período de tiempo específico para medir la velocidad y el cambio de los movimientos de precios de un valor.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI de compañías en Sector Health Care en TSX en comparadas con Theratechnologies
¿Qué hace Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Empresas con rsi similar a Theratechnologies
- Netgem SA tiene RSI de 36.45
- Jersey Oil and Gas Plc tiene RSI de 36.45
- Thor Mining Plc tiene RSI de 36.45
- Solocal tiene RSI de 36.45
- InVivo Therapeutics Corp tiene RSI de 36.46
- World Ltd tiene RSI de 36.46
- Theratechnologies tiene RSI de 36.47
- Innospec Inc tiene RSI de 36.48
- Helios Fairfax Partners tiene RSI de 36.48
- DCD Media Plc tiene RSI de 36.48
- District Metals tiene RSI de 36.48
- iSIGN Media Solutions tiene RSI de 36.49
- Range Resources Corp tiene RSI de 36.49